CERENO SCIENTIFIC AB B (4A1) — Capital Reinvestment Ratio

Latest as of June 2026: 2.51x

CERENO SCIENTIFIC AB B (4A1) has a Capital Reinvestment Ratio of 2.51x as of June 2026, meaning it reinvests 3% of its operating cash flow (€20.90 Million) in capital expenditures (€52.44 Million). Check CERENO SCIENTIFIC AB B tangible book value ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

2.51x

Capex / Operating Cash Flow

Operating Cash Flow

€20.90 Million

EUR

Capital Expenditures

€52.44 Million

EUR

Data as of

Jun 2026

Most recent filing

Annual Capital Reinvestment Ratio for CERENO SCIENTIFIC AB B (None–None)

Year-by-year Capital Reinvestment Ratio for CERENO SCIENTIFIC AB B from None to None. See 4A1 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow